首页> 美国卫生研究院文献>Diabetes >Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel
【2h】

Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel

机译:2型糖尿病易感性基因变体KCNJ11 E23K和ABCC8 S1369A的共表达改变了ATP和K通道对ATP的敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVEIn the pancreatic β-cell, ATP-sensitive K+ (KATP) channels couple metabolism with excitability and consist of Kir6.2 and SUR1 subunits encoded by KCNJ11 and ABCC8, respectively. Sulfonylureas, which inhibit the KATP channel, are used to treat type 2 diabetes. Rare activating mutations cause neonatal diabetes, whereas the common variants, E23K in KCNJ11 and S1369A in ABCC8, are in strong linkage disequilibrium, constituting a haplotype that predisposes to type 2 diabetes. To date it has not been possible to establish which of these represents the etiological variant, and functional studies are inconsistent. Furthermore, there have been no studies of the S1369A variant or the combined effect of the two on KATP channel function.
机译:目的在胰腺β细胞中,ATP敏感性K + (KATP)通道将新陈代谢与兴奋性结合起来,并分别由KCNJ11和ABCC8编码的Kir6.2和SUR1亚基组成。抑制KATP通道的磺酰脲类药物可用于治疗2型糖尿病。罕见的激活突变会导致新生儿糖尿病,而常见的变异(KCNJ11中的E23K和ABCC8中的S1369A)处于强烈的连锁不平衡状态,构成了易患2型糖尿病的单倍型。迄今为止,尚不可能确定其中哪一种代表病因学变异,并且功能研究不一致。此外,还没有关于S1369A变体或两者对KATP通道功能的组合作用的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号